back to top
My wish lists
Save your wish list
If you want to add more content to your wish list, simply log in. If you do not have a user account, please register for the Hanser Customer Center.

» Do you already have a user account? Please log in here.
» Don't have a user account yet? Please register here.
Your wish lists
If you want to use your wish list during your next visit, simply log in. If you do not have a user account, please register for the Hanser Customer Center.
» Do you already have a user account? Please log in here.
» Don't have a user account yet? Please register here.

« Back

Your advantages at a glance

  • One login for all Hanser portals
  • Individual home page for faster access to preferred content
  • Exclusive access to selected content
  • Personal wish lists on all portals
  • Central management of your personal information and newsletter subscriptions

Register now
Deutsch
Bookmark Bookmarked
01-11-2018

New Biopharma Portfolio

For Single-Use Applications

Solvay SA, Brussels, Belgium, has unveiled a broad portfolio of medical-grade specialty polymers for single-use biopharmaceutical manufacturing applications. Encompassing select grades from five of its most recognized product families, the new portfolio aims to support the industry’s shift toward single-use peripherals, filtration, bioreactors and containment. According to Solvay, it will help biopharmaceutical manufacturers achieve greater flexibility, faster product development, reduced capital costs and increased speed to market.

The five product families from which Solvay assembled its new biopharmaceutical manufacturing portfolio include:

  • Radel polyphenylsulfone (PPSU)
  • Udel polysulfone (PSU)
  • AvaSpire polyaryletherketone (PAEK)
  • KetaSpire polyetheretherketone (PEEK)
  • Ixef polyarylamide (PARA)

In qualifying materials for single-use applications, Solvay evaluated the effect of gamma irradiation up to 50 kGy on each polymer to ensure it would retain excellent mechanical performance and other application-critical properties. Results confirmed each material’s compatibility with gamma irradiation, the preferred sterilization method for single-use systems.

All materials are certified under United States Pharmacopeia (USP) Class VI test standards – before and after gamma irradiation – to ensure they meet stringent industry requirements. Solvay is also following industry guidelines to evaluate leachables and extractables for its biopharma portfolio.

Company profile

SOLVAY SA

Rue de Ransbeek 310
BE 1120 BRUSSELS

These articles might be interesting for you
Patents Stimulate Innovation

Patents encourage innovation: Stay on the ball with the latest innovations in the plastics industry in our patents section.

Patents

Newsletter

Would you like to subscribe to our Newsletters on plastics technology and profit from the latest information?

Subscribe here

Subscribe here

Trade Names

You know the trade name but want to know the material manufacturer, type of polymer and delivery form? Search here!

Trade Names